Opendata, web and dolomites

ISSD

The Implantable Subcutaneous String Defibrillator, an innovative subcutaneous cardioverterdefibrillator for a new paradigm in cardiac rhythm management.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ISSD project word cloud

Explore the words cloud of the ISSD project. It provides you a very rough idea of what is the project "ISSD" about.

implantation    impacts    rechargeable    trade    sca    subcutaneous    technologies    icds    invisible    issd    outpatient    implanted    trials    security    global    leads    fast    solutions    cyber    avoiding    wires    aesthetical    causes    point    comfort    move    countries    clinical    dimension    arrest    pose    prevent    rapid    350    replacement    stage    inserted    untouched    market    defibrillators    plan    vascular    subcutaneously    view    meet    death    wireless    3m    totally    lives    solid    claiming    helped    life    implantable    device    efficiency    first    snake    deployment    almost    threating    investment    robustness    introduces    rates    deploy    carry    demand    chain    min    procedure    financial    commercialisation    overcome    complications    designed    patients    8m    instrument    cardiac    heart    sudden    drawbacks    seamless    generators    cardioverter    remaining    europe2    halving    fits    sound    barriers    sme    improves    veins    icd    scas    invested    transvenous   

Project "ISSD" data sheet

The following table provides information about the project.

Coordinator
NEWPACE LTD 

Organization address
address: 13 GRANITH ST
city: CAESAREA
postcode: 3088900
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.newpacemedical.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-11-01   to  2018-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NEWPACE LTD IL (CAESAREA) coordinator 50˙000.00

Map

 Project objective

Sudden Cardiac Arrest (SCA) is a life-threating heart condition and one of the most common causes of death in developed countries claiming more than 350,000 lives per year in Europe2. There are currently two different implantable technologies to prevent SCAs: 1) Transvenous Implantable Cardioverter-Defibrillators (T-ICDs), which are implanted with wires that snake through veins into the heart; and 2) Subcutaneous Implantable Cardioverter-Defibrillators (S-ICD), which also have generators and leads but avoiding leads within the heart. However this solutions pose many drawbacks such as major complications to the vascular system, replacement needs, aesthetical and comfort impacts, complex implantation procedures and cyber-security issues.

The ISSD™ introduces a new dimension in subcutaneous ICDs. It is a totally integrated device fully inserted subcutaneously, with no leads within the heart, thus remaining the vascular system untouched. It is a wireless rechargeable device, halving replacement rates when compared to current technologies and it is totally seamless and integrated, so no generators or leads are needed. This makes the device almost invisible and improves patients comfort. It is designed from a cyber-security point of view and can be implanted in a rapid outpatient procedure (20 min on average).

So far, we have invested €8M which have helped us to ensure its robustness and efficiency and move into the commercialisation stage. To further develop the ISSD™, overcome market barriers and deploy it at a European and global level we need a further investment of €3M which will allow us to carry out clinical trials and set up a solid EU value chain able to meet the large demand expected during the first years of commercialisation.

The proposed work in Phase 1 of the SME instrument fits into our overall plan to reach the market by contributing the financial resources needed to plan a fast sound wider deployment of the ISSD™ and its market uptake.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ISSD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ISSD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

SOFT (2017)

SOFT, the first camera-based colorectal cancer screening test to detect occult blood in faeces immediately and with no lab analysis.

Read More  

REALM (2015)

A disruptive method to free physicians from Hospital Information Systems by generating fault free patient diagnostic documents in real-time using natural language

Read More  

WIMUACT (2017)

TECHNOLOGY FOR THE IMPROVEMENT OF SPORTS PERFORMANCE IN NON-PROFESSIONAL CONTEXTS

Read More